Cardiovascular disease in type 1 diabetes, an underestimated danger: Epidemiological and pathophysiological data

2023/06/21 by Bruno Vergès · 27 citations
Medicine · Biochemistry, Genetics and Molecular Biology · #Diabetes Management and Research #Diabetes and associated disorders #Pancreatic function and diabetes

paper · doi:10.1016/j.atherosclerosis.2023.06.005

Citations

• Higher Plasma Methylglyoxal Levels Are Associated With Incident Cardiovascular Disease in Individuals With Type 1 Diabetes: A 12-Year Follow-up Study

Cited by

• Liraglutide-Conjugated Poly(methyl vinyl ether-alt-maleic acid)-Coated Core–Shell Upconversion Nanoparticles for Theranostics of Diabetes
• Familial Hypercholesterolemia in Pediatric Patients With Type 1 Diabetes: Double Challenge for Diagnosis and Treatment
• Antioxidant and Anti-Inflammatory Functions of High-Density Lipoprotein in Type 1 and Type 2 Diabetes. [europepmc]
• Screening for Subclinical Atherosclerosis and the Prediction of Cardiovascular Events in People with Type 1 Diabetes. [europepmc]
• Sex inequalities in cardiovascular risk factors and their management in primary prevention in adults living with type 1 diabetes in Germany and France: findings from DPV and SFDT1. [europepmc]
• The Endogenous Inhibitor of CETP, apoC1, Remains Ineffective In Vivo after Correction of Hyperglycemia in People with Type 1 Diabetes. [europepmc]
• Glucometabolic Efficacy of the Empagliflozin/Metformin Combination in People with Type 1 Diabetes and Increased Cardiovascular Risk: A Sub-Analysis of a Pilot Randomized Controlled Trial. [europepmc]
• Early increase in carotid intima-media thickness in women with childhood-onset type 1 diabetes compared with healthy peers: the Norwegian Atherosclerosis and Childhood Diabetes study. [europepmc]
• Unveiling the Therapeutic Potential of the Second-Generation Incretin Analogs Semaglutide and Tirzepatide in Type 1 Diabetes and Latent Autoimmune Diabetes in Adults. [europepmc]
• Glycemic Variability and Its Association with Traditional Glycemic Control Biomarkers in Patients with Type 1 Diabetes: A Cross-Sectional, Multicenter Study. [europepmc]
• Therapeutic potential of anti-thymocyte globulin in type 1 diabetes: A systematic review. [europepmc]
• Management of dyslipidaemia in patients with comorbidities-facing the challenge: type 1 diabetes mellitus. [europepmc]
• Beyond overweight, visceral adiposity is associated with estimation of cardiovascular risk in patients living with type 1 diabetes: findings from the SFDT1 cohort. [europepmc]
• Luteolin reduces necroptosis in the diabetic heart after cardiac arrest and resuscitation by activating sirtuin 3. [europepmc]
• Liraglutide-Conjugated Poly(methyl vinyl ether- alt -maleic acid)-Coated Core-Shell Upconversion Nanoparticles for Theranostics of Diabetes. [europepmc]
• Incretin-Based Adjunct to Background Insulin Treatment for Managing Body Weight Excess in Type 1 Diabetes: An Expert Opinion Viewpoint From the Italian Association of Clinical Endocrinologists. [europepmc]
• The Glycemia Risk Index (GRI) as a Biomarker for Subclinical Endothelial Dysfunction in Type 1 Diabetes: A Cross-Sectional Study. [europepmc]
• Diabetes Mellitus and Cardiopulmonary Bypass (CPB): Pathophysiological Mechanisms Related to Inflammation and Cardiovascular Disease. [europepmc]
• Preventing and Managing Vascular Complications in Adolescents With Type 1 Diabetes. [europepmc]
• Sudomotor dysfunction reflects early atherosclerosis risk in adults with type 1 diabetes. [europepmc]
• Adrenaline is a prominent driver of inflammatory responses following hypoglycaemia. [europepmc]
• The shared genetic architecture underlying the autoimmune and cardiovascular disease: a multivariate genome-wide analysis. [europepmc]
• Demographic Change in Prevalent Type 1 Diabetes Adult Population, and Association of Risk Factors With Comorbidities and Mortality-Results From the Finnish Diabetes Control Study FinDiCon. [europepmc]
• Cardiovascular risk equations in type 1 diabetes: from generic models to personalized prediction. [europepmc]
• Precision cardiovascular risk prediction in type 1 diabetes: An IMI2 SOPHIA analysis. [europepmc]
• Sex differences in cardiovascular disease risk in type 1 diabetes: The vascular bed paradox in women. [europepmc]
• Type 1 Diabetes and Cardiovascular Risk: The Current Management Strategies [europepmc]